Experiment 75636
Compounds isolated
Details
| Property | Value |
|---|---|
| Pharmacology | |
| Administration route | IV |
| Organism | Empty organism |
| Citation | FUJITA,J: SAIJO,N: EGUCHI,K: SHINKAI,T: TOMINAGA,K: SASAKI,Y: FUTAMI,H: SAKURAI,M: ISHIHARA,J: TAKAHASHI,H: HOSHI,A:. (1985). PHASE II STUDY OF VINDESINE IN PATIENTS WITH NON-SMALL CELL LUNG CANCER.. 76(9) |
| Amount utilized | |
| Compound isolated | |
| Disease | IN THIS PHASE II STUDY, 21 PATIENTS WITH SMALL CELL LUNG CANCER WERE TREATED. OVERALL RESPONSE RATE WAS 14.3%. THERE WERE NO COMPLETE REMISSIONS. THREE PARTIAL REMISSIONS WERE SEEN OF 4,5 AND 12 PLUS MONTHS DURATION. MYELOSUPPRESSION WAS THE DOSE LIMITING SIDE EFFECT WITH LEUKOPENIA BEING COMMON. CUMULATIVE MILD PERIPHERAL NEUROPATHY WAS SEEN IN 11 PATIENTS. SERUM GOT AND/OR GPT. |
| Dose amount | 3.0 MG |
| Number | 1 |
| Qualitative result | EQUIVOCAL |
| Animal | HUMAN ADULT |
| Per unit | SQ M BODY SURFACE |
| Dose expression | DOSE |